Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I W Gibson

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2013
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomesC Wiebe, D Pochinco, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 20, 2016
Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft SurvivalC Wiebe, A J Gareau, D Pochinco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 24, 2013
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injuryD E Hricik, P Nickerson, R N Formica, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2015
Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter StudyD E Hricik, J Augustine, P Nickerson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 16, 2017
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trialsM Haas, A Loupy, C Lefaucheur, et al.
Kidney International|February 13, 1999
The Banff 97 working classification of renal allograft pathologyL C Racusen, K Solez, R B Colvin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesionsM Haas, B Sis, L C Racusen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 26, 2008
Banff 07 classification of renal allograft pathology: updates and future directionsK Solez, R B Colvin, L C Racusen, et al.
Transplantation Proceedings|February 1, 1996
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathologyK Solez, H Benediktsson, T Cavallo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2016
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyA Loupy, M Haas, K Solez, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 30, 2013
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomesC Wiebe, D Pochinco, T D Blydt-Hansen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 20, 2016
Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft SurvivalC Wiebe, A J Gareau, D Pochinco, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 24, 2013
Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injuryD E Hricik, P Nickerson, R N Formica, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 1, 2015
Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter StudyD E Hricik, J Augustine, P Nickerson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 16, 2017
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trialsM Haas, A Loupy, C Lefaucheur, et al.
Kidney International|February 13, 1999
The Banff 97 working classification of renal allograft pathologyL C Racusen, K Solez, R B Colvin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesionsM Haas, B Sis, L C Racusen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 26, 2008
Banff 07 classification of renal allograft pathology: updates and future directionsK Solez, R B Colvin, L C Racusen, et al.
Transplantation Proceedings|February 1, 1996
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathologyK Solez, H Benediktsson, T Cavallo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 19, 2016
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular PathologyA Loupy, M Haas, K Solez, et al.
Pageof 4